435 Devon Park Drive
United States - Map
|Full Time Employees:||36|
Medgenics, Inc., a medical technology and therapeutics company, is engaged in the research and development of products in the field of biotechnology and associated medical equipment in the United States. The company develops and commercializes Biopump platform technology that converts a piece of the patients own dermal skin tissue into a protein- and/or peptide-producing Biopump to produce and deliver therapeutic proteins and/or peptides, andwhen implanted under the patients skinhas the potential to deliver various months of protein/peptide therapy. Its product candidates include EPODURE Biopump, which is in Phase I/II clinical trials for the treatment of anemia in CKD and renal failure; and HEMODURE Biopump, which is under pre-clinical studies and produces Factor VIII for the treatment of patients with hemophilia. The company also develops INFRADURE Biopump that produces interferon-alpha for the treatment of patients with hepatitis C. Medgenics, Inc. was founded in 2000 and is based in Wayne, Pennsylvania.
|Dr. Andrew Leonard Pearlman Ph.D.,
Founder, Sr. Advisor and Director
|Dr. Eugene Andrew Bauer M.D.,
Consultant, Director and Member of Strategic Advisory Board
|Mr. Michael F. Cola ,
Chief Exec. Officer, Pres and Director
|Dr. John H. Leaman M.D.,
Chief Financial Officer
|Ms. Phyllis K. Bellin M.B.A.,
VP of Admin.
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|